.svg){kind=small}
Aug-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Ilera Healthcare has shown a dynamic performance in the Maryland cannabis market, particularly in the Concentrates category. In May 2024, Ilera Healthcare did not rank in the top 30 brands, but by June 2024, they managed to secure the 27th position. This upward trend continued, and by August 2024, they had climbed significantly to rank 16th. This indicates a positive movement and growing consumer interest in their concentrate products. The absence of a ranking in May and July suggests that while the brand may have faced challenges, their overall trajectory is upward, which is promising for their future market presence.
While the sales data for certain months are not disclosed, the available figures show a significant increase in August compared to May. This trend highlights that Ilera Healthcare's strategies in Maryland are starting to pay off, particularly in the Concentrates category. However, the fluctuations in their ranking underscore the competitive nature of the market. The brand's ability to break into the top 30 and then improve its position suggests that they are effectively responding to market demands and consumer preferences. Further analysis would be needed to understand the specific factors driving these changes, but the data available points to a brand that is gaining traction and could potentially continue this positive trend.
Competitive Landscape
In the Maryland concentrates market, Ilera Healthcare has experienced notable fluctuations in its rank and sales over the past few months. After not being in the top 20 in May and June 2024, Ilera Healthcare made a significant leap to rank 16th in July 2024, indicating a strong upward trend in sales performance. This rise is particularly impressive when compared to competitors like Kind Tree Cannabis, which consistently held higher ranks, peaking at 14th in August 2024, and #Hash, which maintained a steady presence in the top 20, ranking as high as 13th in July 2024. Meanwhile, Modern Flower and Temple also showed varied performances, with Modern Flower re-entering the top 20 in June and Temple slipping to 21st by August. These dynamics suggest that while Ilera Healthcare is gaining momentum, it faces stiff competition from established brands, making it crucial for them to sustain their growth trajectory to secure a more stable position in the market.
Notable Products
In August 2024, the top-performing product from Ilera Healthcare was the Indica Blend RSO Dablicator (1g) in the Concentrates category, maintaining its first-place ranking from previous months and achieving a notable sales figure of 413 units. The Butter Mintz Dablicator (1g), also in the Concentrates category, secured the second position, climbing from its fourth rank in June 2024 with 234 units sold. The Butter Mintz RSO Dablicator (1g) dropped to third place from its consistent second-place ranking in June and July 2024, with sales reaching 223 units. The Indica Live RSO Dablicator (1g) did not have recorded sales data for August, but it previously held the fourth rank in June 2024. Overall, the top products have shown consistent performance with some fluctuations in rankings, reflecting dynamic sales trends in the Concentrates category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
